Amy Wolbeck is VP at Intersect ENT, Inc. (XENT). They have made 3 open-market trades across 1 company since 2015, most recently 2016-09-07.
CIK 0001271214
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENT | 5,700 | $161K |
Shares reported on the most recent Form 4, priced at the 2016-09-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENT | SELL | 2016-09-07 | 2016-09-08 | $15.67 | $136K | -2.2% | +8.0% | -30.6% |
| XENT | SELL | 2016-09-06 | 2016-09-08 | $15.83 | $907K | -2.2% | +8.0% | -30.6% |
| XENT | SELL | 2016-09-06 | 2016-09-08 | $15.90 | $318K | -2.2% | +8.0% | -30.6% |
| XENT | SELL · 10b5-1 | 2016-04-27 | 2016-04-28 | $20.01 | $40K | -27.4% | -33.9% | -19.8% |
| XENT | SELL · 10b5-1 | 2015-05-11 | 2015-05-11 | $23.10 | $2K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-04-13 | 2015-04-15 | $26.25 | $420K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-03-11 | 2015-03-13 | $23.06 | $184K | -14.6% | -3.7% | -3.7% |
| XENT | SELL · 10b5-1 | 2015-02-11 | 2015-02-13 | $22.12 | $177K | -14.6% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.